Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Jul 28, 2021
Date Accepted: Sep 7, 2021

The final, peer-reviewed published version of this preprint can be found here:

Effectiveness of Contact Tracing for Viral Disease Mitigation and Suppression: Evidence-Based Review

Craig KJ, Rizvi R, Willis VC, Kassler WJ, Jackson GP

Effectiveness of Contact Tracing for Viral Disease Mitigation and Suppression: Evidence-Based Review

JMIR Public Health Surveill 2021;7(10):e32468

DOI: 10.2196/32468

PMID: 34612841

PMCID: 8496751

Effectiveness of Contact Tracing on Viral Disease Mitigation and Suppression: An Evidence-Based Review

  • Kelly Jean Craig; 
  • Rubina Rizvi; 
  • Van C Willis; 
  • William J Kassler; 
  • Gretchen Purcell Jackson

ABSTRACT

Background:

Contact tracing in association with quarantine and isolation is an important public health tool to control outbreaks of infectious diseases. This strategy has been widely implemented in the current coronavirus disease 2019 (COVID-19) pandemic. The effectiveness of this non-pharmaceutical intervention (NPI) is largely dependent on social interactions within the population and its combination with other interventions. Given the high transmissibility of SARS-CoV-2, small serial intervals, and asymptomatic transmission patterns, the effectiveness of contact tracing for this novel agent is largely unknown.

Objective:

To identify and synthesize evidence regarding the effectiveness of contact tracing on infectious viral disease outcomes based on prior scientific literature.

Methods:

An evidence-based review was conducted to identify studies from MEDLINE (including pre-print medRxiv server content) related to the effectiveness of contact tracing in viral outbreaks. The search dates were from database inception to July 24, 2020. Outcomes of interest were measures of incidence, transmission, hospitalization, and mortality.

Results:

Out of 159 unique records retrieved, 45 records were reviewed at the full-text level, with 24 meeting all inclusion criteria. Included studies utilized mathematical modeling (n=14), observational (n=8), and systematic review (n=2) approaches. Only two studies considered digital contact tracing. Contact tracing was mostly evaluated in combination with other NPIs and/or pharmaceutical interventions (PIs). While some degree of effectiveness in decreasing viral disease incidence, transmission, and resulting hospitalizations and mortality was observed, these results were highly dependent on epidemic severity (R0 value), number of contacts traced (including pre-symptomatic and asymptomatic cases), timeliness, duration, and compliance with combination interventions such as isolation, quarantine, and treatment. Contact tracing effectiveness was particularly limited by logistical challenges associated with increased outbreak size and speed of spread.

Conclusions:

Timely deployment of contact tracing strategically layered with other NPIs could be an effective public health tool for mitigating and suppressing infectious outbreaks by decreasing viral disease incidence, transmission, and resulting hospitalizations and mortality.


 Citation

Please cite as:

Craig KJ, Rizvi R, Willis VC, Kassler WJ, Jackson GP

Effectiveness of Contact Tracing for Viral Disease Mitigation and Suppression: Evidence-Based Review

JMIR Public Health Surveill 2021;7(10):e32468

DOI: 10.2196/32468

PMID: 34612841

PMCID: 8496751

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement